Consequently, our results suggest that lifestyle and pharmacological intervention for boosting adiponectin levels to improve serum lipoprotein status would be successful primarily in healthy males, but not females, as well as in females, but not males with MS. Here, ADIPOQ is linked to myeloid sarcoma.